Of course the data was held back, it would hurt sales. This is extremely typical of psychiatric drugs. Typically we only find these things out after the drug ha

Of course the data was held back, it would hurt sales. This is extremely typical of psychiatric drugs. Typically we only find these things out after the drug has been on the market for a number of years, with predictable (had we known!) consequences. Pharmas need to be held accountable for this bad behavior and all clinical trial results (including negative results) need to be 100% transparent. I am going to be blunt: this would massively hurt their bottom line. Because accountability would hurt the pharmas bottom line, it will be like pulling teeth to get any kind of legislation to fix this problem-- they love to buy politicians specifically because it protects them in times like these where they have done wrong. We need to stop allowing "because money" to be a valid reason for allowing people to get hurt. Psychiatric drugs are huge cash cows and are very frequently (see numerous meta-analyses) only dubiously or narrowly effective. They're a stopgap for a missing mental healthcare system, and allowed a lot of leeway because of this.